Saving changes...

Done

Error

VCS 2020: Chemotherapy Safety & USP800 Compliance "FAQ's Galore" An Open Diaglogue

VCS 2020: Chemotherapy Safety & USP800 Compliance "FAQ's Galore" An Open Diaglogue

VCS 2020: Chemotherapy Safety & USP800 Compliance "FAQ's Galore" An Open Diaglogue

Jenny Cassibry Fisher
Jenny Cassibry Fisher
on behalf of Missouri Veterinary Medical Association

$FREE $ FREE $ FREE

$ FREE FREE FREE
$ 25.00 25.00 25.00
Normal Price: FREE $25.00

Review:

Launch date: 22 Nov 2020
Expiry Date:

Last updated: 27 Jan 2021

Reference: 196345

TIming: null

Maximum Attendees:

Places Left: 0

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

Ms Karen Becki CVT, VTS (Oncology) (15 Jan 2021)
Very informative! Thanks, again, Jenny for another great lecture. I really enjoyed it!

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

You have null days left.

Description

Topic: Chemotherapy Safety & USP800 Compliance "FAQ's Galore" An Open Diaglogue
The National Institute for Occupational Safety and Health (NIOSH) have set criteria for what “Makes a HD”. The six criteria include: carcinogenicity, teratogenicity, reproductive toxicity, organ toxicity at low doses, genotoxicity, structure, and toxicity profiles that mimic drugs deemed HD by previous stated criteria. These criteria were originally set in the late 1970’s – years before genetically modified drugs and some of the other treatment modalities available today. As many older regulations, these also need to be adjusted based with progressive modern medicine. Many groups/governing bodies exist to evaluate and develop safety protocols based upon specific criteria. One of these agencies is USP. The most current hazardous drug handling recommendations are outlined in USP 800.
Implementing these new guidelines will require hospitals to adapt new technology, gain additional training and potentially change the facility physical structure. Four main points of USP 800 require the use of PPE, CSTD, class IIb hood and a negative pressure room. All four of these points will be required for any facility to pass compliance. Enforcement will mainly lie within state regulations and it is unclear at this time the true impact financially. Routes of potential exposure are also included in 800, including receipt, unpacking and storage of HD.
Chemotherapy safety is a constant topic for veterinary oncology personnel. Over the past few years, with the publishing of USP800 many veterinary facilities have been trying to understand the recommendations and become compliant. Safety guidelines and topics are typically not a subjective conversation. This lecture will cover updates and frequently asked questions regarding USP800 compliance.
Exam offered and MVMA CE certificate issued following presentation.

Objectives

Identify the current guidelines for hazardous drug handling
Identify the NIOSH hazardous drug list and its groups
Identify safety principles for group one hazardous drug delivery
Jenny Cassibry Fisher

Author Information Play Video Bio

Jenny Cassibry Fisher
on behalf of Missouri Veterinary Medical Association

Jenny Cassibry Fisher, RVT, VTS-Oncology
Employer: PractiVet – Education Director
Jenny has worked in veterinary medicine, in some regard for over 25 years, receiving her RVT in 2001 and her VTS (IM-oncology) in 2015. Her clinical experience includes, academia, general medicine and emergency medicine. Jenny Spent 14 years as the head oncology technician at LSU veterinary teaching hospital, cancer treatment unit, where she worked in the clinic as a medical and radiation oncology technician. Her teaching credentials include lecturing on the regional and national level, teaching fourth year veterinary students and lecturing at multiple veterinary technology programs. Jenny won the Susan Weeks nursing excellence award at LSU-SVM in 2008. She was also the clinical coordinator for the Baton Rouge Community College veterinary technology program in 2017. Her lectures cover relevant topics such as fluid therapy, oncology overview, going needle free, cytology, closed system transfer devices, chemotherapy safety, chemotherapy administration and radiation toxicity management and many others. Her main clinical interests include, radiation therapy patient positioning, chemotherapy and radiation safety, paraneoplastic syndromes and integrative medicine. Currently, Jenny serves as the nominations chair for the academy of internal medicine for veterinary technicians (AIMVT) is a member of NAVTA and VCS. Jenny was recently named as one of the top ten veterinary technicians to follow in DVM360 (T. Mcneraney). One of her biggest accomplishments has been serving on the NORA sector council with NIOSH. Jenny has helped to develop training programs and applications for veterinary healthcare workers handling hazardous drugs. Jenny works as the education director for PractiVet and as a consultant for many private practices and universities in their oncology departments. Jenny lives in Baton Rouge with her husband, stepdaughter and a menagerie of pets.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Missouri Veterinary Medical Association
  • 1.00 Hours -
    Exam Attempts: 3
    -
    Exam Pass Rate: 60

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (1)

Go Back
Ms Karen Becki CVT, VTS (Oncology) (15 Jan 2021)
Very informative! Thanks, again, Jenny for another great lecture. I really enjoyed it!

Loading...


Saving changes...

Done

Error